Tesamorelin is an FDA-approved prescription therapeutic (brand name Egrifta) for a specific clinical indication, and its use for general bodybuilding, fat loss, or anti-aging purposes in people without that diagnosis is an off-label application, not an over-the-counter supplement use
10.1038/s41392-020-00428-9 82
Drug - Drug interactions: Before receiving B 29 AQ 1500MCG PREFILLED SYRINGE(PFS), inform your doctor if you are receiving any of the following medicine: neomycin (used to prevent/manage bacterial skin infections) amino salicylic acid (used to manage tuberculosis) histamine H2-antagonists (used to manage recurrence of duodenal ulcers) Ex
AOD 9604 Comparison: Related Research Compounds The table below compares AOD 9604 with two growth hormonereleasing hormone analogues, CJC-1295 and tesamorelin
The potential for dangerous interactions, hormonal disruption, and additive side effects is entirely unknown, and no regulatory body endorses such combinations